Skip to main content
logo
Sarepta Therapeutics, Inc. (SRPT)
NASDAQ: SRPT · Real-Time Price · USD
18.10
-0.32 (-1.74%)
At close: Aug 14, 2026, 4:00 PM EDT
17.78
-0.32 (-1.77%)
After-hours: Aug 14, 2026, 7:34 PM EDT

Sarepta Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,9742,1981,9021,243933.01701.89
Revenue Growth
-20.44%15.58%52.97%33.26%32.93%29.95%
Gross Profit
-341.55-163.43778.36215.61-84.07-160.24
Operating Income
-62.24-657.77218.08-267.82-536.2-443.61
Net Income
-136.73-713.41235.24-535.98-703.49-418.78
Earnings Per Share
-1.32-7.132.34-5.80-8.03-5.15
EPS Growth
------

Revenue by Segment
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total PMO Products
956.87965.57967.17944.52843.77612.4
ELEVIDYS
441.99898.73820.79200.36--
Collaboration and Other
575.49333.94114.0298.4689.2489.49
Revenue (Total)
1,9742,1981,9021,243933.01701.89

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
788.49939.651,3551,6761,9892,116
Total Debt
1,0621,0401,3301,3791,6171,138
Net Cash (Debt)
-273.92-99.925.2297.29372.02977.48
Net Cash Growth
---91.53%-20.09%-61.94%12.91%
Net Cash Per Share
-2.64-1.000.233.224.2512.03

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
111.01-205.48-205.79-500.99-325.35-443.17
Capital Expenditures
-29.16-101.97-136.96-76.11-30.82-38.49
Free Cash Flow
81.85-307.45-342.74-577.1-356.17-481.66
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-17.30%-7.43%40.92%17.34%-9.01%-22.83%
Operating Margin
-3.15%-29.92%11.47%-21.54%-57.47%-63.20%
Pretax Margin
-6.63%-31.94%13.71%-41.83%-73.95%-59.69%
Profit Margin
-6.93%-32.45%12.37%-43.11%-75.40%-59.66%
FCF Margin
4.15%-13.99%-18.02%-46.41%-38.17%-68.62%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
--49.37---
Forward PE
32.7090.1215.47---
PS Ratio
0.971.036.117.2612.1911.17